← Open Payments lookup

GARRY GRAYSON: Open Payments

NPI 1043260409 · BIRMINGHAM, AL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$203 in 8 payments from 7 companies in 2025. Trend: 2023 $148 · 2024 $156 · 2025 $203

Food & beverage: $203
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.2$56
Neurocrine BioSciences, Inc.1$38
Vanda Pharmaceuticals Inc.1$36
Takeda Pharmaceuticals U.S.A., Inc.1$23
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)1$20
Lundbeck LLC1$17
Teva Pharmaceuticals USA, Inc.1$14

Products named: REXULTI, INGREZZA, FANAPT, TRINTELLIX, CAPLYTA, UZEDY.

Industry payments across AL — which companies pay providers there.